Search Results - Maria E. Arcila

Refine Results
  1. 1
    Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR

    Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR by Marie Brevet, Maria E. Arcila, Marc Ladanyi

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Cerebrospinal fluid: A unique source of circulating tumor DNA with broad clinical applications

    Cerebrospinal fluid: A unique source of circulating tumor DNA with broad clinical applications by Richard A. Hickman, Alexandra Miller, Maria E. Arcila

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Detection of KRAS and BRAF Mutations in Colorectal Carcinoma

    Detection of KRAS and BRAF Mutations in Colorectal Carcinoma by Maria E. Arcila, Christopher Lau, Khédoudja Nafa, Marc Ladanyi

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    MET-dependent solid tumours — molecular diagnosis and targeted therapy

    MET-dependent solid tumours — molecular diagnosis and targeted therapy by Robin Guo, Jia Luo, Jason C. Chang, Natasha Rekhtman, Maria E. Arcila, Alexander Drilon

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    New Strategies in Overcoming Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancer

    New Strategies in Overcoming Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancer by Geoffrey R. Oxnard, Maria E. Arcila, Juliann Chmielecki, Marc Ladanyi, Vincent A. Miller, William Pao

    Published 2011
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Outcomes of chemotherapies and HER2 directed therapies in advanced HER2-mutant lung cancers

    Outcomes of chemotherapies and HER2 directed therapies in advanced HER2-mutant lung cancers by Juliana Eng, Meier Hsu, Jamie E. Chaft, Mark G. Kris, Maria E. Arcila, Bob T. Li

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing

    Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing by Helena A. Yu, Maria E. Arcila, Matthew D. Hellmann, Mark G. Kris, Marc Ladanyi, Gregory J. Riely

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Acquired Resistance of<i>EGFR-</i>Mutant Lung Cancer to a T790M-Specific EGFR Inhibitor

    Acquired Resistance of<i>EGFR-</i>Mutant Lung Cancer to a T790M-Specific EGFR Inhibitor by Helena A. Yu, Shaozhou K. Tian, Alexander Drilon, Laetitia Borsu, Gregory J. Riely, Maria E. Arcila, Marc Ladanyi

    Published 2015
    Get full text
    Carta
    Save to List
    Saved in:
  9. 9
    Screening for Germline EGFR T790M Mutations Through Lung Cancer Genotyping

    Screening for Germline EGFR T790M Mutations Through Lung Cancer Genotyping by Geoffrey R. Oxnard, Vincent A. Miller, Mark E. Robson, Christopher G. Azzoli, William Pao, Marc Ladanyi, Maria E. Arcila

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Optimizing Workflows and Processing of Cytologic Samples for Comprehensive Analysis by Next-Generation Sequencing: Memorial Sloan Kettering Cancer Center Experience

    Optimizing Workflows and Processing of Cytologic Samples for Comprehensive Analysis by Next-Generation Sequencing: Memorial Sloan Kettering Cancer Center Experience by Shaozhou K. Tian, Jonathan Keith Killian, Natasha Rekhtman, Ryma Benayed, Sumit Middha, Marc Ladanyi, Oscar Lin, Maria E. Arcila

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials

    Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials by David M. Hyman, David B. Solit, Maria E. Arcila, Donavan T. Cheng, Paul Sabbatini, José Baselga, Michael F. Berger, Marc Ladanyi

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Clinical Characteristics of Patients With Lung Adenocarcinomas Harboring <i>BRAF</i> Mutations

    Clinical Characteristics of Patients With Lung Adenocarcinomas Harboring <i>BRAF</i> Mutations by Paul K. Paik, Maria E. Arcila, Michael Fara, Camelia S. Sima, Vincent A. Miller, Mark G. Kris, Marc Ladanyi, Gregory J. Riely

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma

    KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma by Kyuichi Kadota, Camelia S. Sima, Maria E. Arcila, Cyrus V. Hedvat, Mark G. Kris, David R. Jones, Prasad S. Adusumilli, William D. Travis

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Multicolor Flow Cytometry and Multigene Next-Generation Sequencing Are Complementary and Highly Predictive for Relapse in Acute Myeloid Leukemia after Allogeneic Transplantation

    Multicolor Flow Cytometry and Multigene Next-Generation Sequencing Are Complementary and Highly Predictive for Relapse in Acute Myeloid Leukemia after Allogeneic Transplantation by Bartlomiej Getta, Sean M. Devlin, Ross L. Levine, Maria E. Arcila, Abhinita Mohanty, Ahmet Zehir, Martin S. Tallman, Sergio Giralt, Mikhail Roshal

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Additional Primary Malignancies in Patients with Gastrointestinal Stromal Tumor (GIST): A Clinicopathologic Study of 260 Patients with Molecular Analysis and Review of the Literature

    Additional Primary Malignancies in Patients with Gastrointestinal Stromal Tumor (GIST): A Clinicopathologic Study of 260 Patients with Molecular Analysis and Review of the Literatu... by Jaclyn F. Hechtman, Ronald P. DeMatteo, Khédoudja Nafa, Ping Chi, Maria E. Arcila, Snjezana Doğan, Alifya Oultache, Wen Chen, Meera Hameed

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    <i>EGFR</i> Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics

    <i>EGFR</i> Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics by Maria E. Arcila, Khédoudja Nafa, Jamie E. Chaft, Natasha Rekhtman, Christopher Lau, Boris Reva, Maureen F. Zakowski, Mark G. Kris, Marc Ladanyi

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    NF1 Mutations Are Common in Desmoplastic Melanoma

    NF1 Mutations Are Common in Desmoplastic Melanoma by Thomas Wiesner, Maija Kiuru, Sasinya N. Scott, Maria E. Arcila, Allan C. Halpern, Travis J. Hollmann, Michael F. Berger, Klaus J. Busam

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Feasibility of endobronchial ultrasound transbronchial needle aspiration for massively parallel next-generation sequencing in thoracic cancer patients

    Feasibility of endobronchial ultrasound transbronchial needle aspiration for massively parallel next-generation sequencing in thoracic cancer patients by Simon R. Turner, Darren J. Buonocore, Patrice Desmeules, Natasha Rekhtman, Snjezana Doğan, Oscar Lin, Maria E. Arcila, David R. Jones, James Huang

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    <i>MAP2K1</i> (<i>MEK1</i>) Mutations Define a Distinct Subset of Lung Adenocarcinoma Associated with Smoking

    <i>MAP2K1</i> (<i>MEK1</i>) Mutations Define a Distinct Subset of Lung Adenocarcinoma Associated with Smoking by Maria E. Arcila, Alexander Drilon, Brooke E. Sylvester, Christine M. Lovly, Laetitia Borsu, Boris Reva, Mark G. Kris, David B. Solit, Marc Ladanyi

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Germline EGFR T790M Mutation Found in Multiple Members of a Familial Cohort

    Germline EGFR T790M Mutation Found in Multiple Members of a Familial Cohort by Helena A. Yu, Maria E. Arcila, Megan Harlan Fleischut, Zsofia K. Stadler, Marc Ladanyi, Michael F. Berger, Mark E. Robson, Gregory J. Riely

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: